Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy | 9 | 2023 | 43 | 2.760 |
Why?
|
| Depression | 5 | 2022 | 712 | 0.710 |
Why?
|
| Quality of Life | 5 | 2023 | 481 | 0.480 |
Why?
|
| Genome-Wide Association Study | 3 | 2019 | 333 | 0.300 |
Why?
|
| Seizures | 2 | 2023 | 68 | 0.260 |
Why?
|
| Adult | 15 | 2023 | 11712 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 643 | 0.250 |
Why?
|
| Humans | 25 | 2023 | 37093 | 0.240 |
Why?
|
| Middle Aged | 13 | 2023 | 10129 | 0.230 |
Why?
|
| Life Style | 2 | 2023 | 308 | 0.230 |
Why?
|
| Adaptation, Psychological | 3 | 2022 | 385 | 0.220 |
Why?
|
| Databases, Factual | 2 | 2019 | 291 | 0.190 |
Why?
|
| Suicide | 1 | 2021 | 118 | 0.180 |
Why?
|
| Hypertension | 4 | 2016 | 796 | 0.180 |
Why?
|
| Female | 14 | 2023 | 20969 | 0.170 |
Why?
|
| Male | 13 | 2023 | 20025 | 0.170 |
Why?
|
| Epidemiologic Studies | 1 | 2019 | 31 | 0.170 |
Why?
|
| Phenotype | 2 | 2019 | 689 | 0.170 |
Why?
|
| Stress, Psychological | 3 | 2022 | 583 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 664 | 0.160 |
Why?
|
| United States | 5 | 2023 | 4223 | 0.160 |
Why?
|
| Depressive Disorder | 1 | 2019 | 174 | 0.150 |
Why?
|
| Disease Management | 1 | 2017 | 61 | 0.140 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2016 | 26 | 0.140 |
Why?
|
| Immune System Diseases | 1 | 2016 | 21 | 0.140 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 7 | 0.140 |
Why?
|
| Dinoprost | 1 | 2016 | 22 | 0.140 |
Why?
|
| Genetic Loci | 1 | 2016 | 90 | 0.140 |
Why?
|
| Leukocytes | 1 | 2016 | 72 | 0.130 |
Why?
|
| Mutation, Missense | 1 | 2016 | 83 | 0.130 |
Why?
|
| Telemedicine | 1 | 2019 | 182 | 0.130 |
Why?
|
| Blood Platelets | 1 | 2016 | 77 | 0.130 |
Why?
|
| Social Class | 1 | 2017 | 247 | 0.130 |
Why?
|
| Telomere | 1 | 2016 | 56 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1369 | 0.130 |
Why?
|
| Sickle Cell Trait | 1 | 2014 | 17 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 767 | 0.120 |
Why?
|
| Albuminuria | 1 | 2014 | 76 | 0.120 |
Why?
|
| Prejudice | 2 | 2005 | 110 | 0.120 |
Why?
|
| Genetic Variation | 1 | 2016 | 387 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 2721 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 169 | 0.100 |
Why?
|
| Georgia | 3 | 2023 | 174 | 0.100 |
Why?
|
| Anticonvulsants | 2 | 2021 | 34 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 2379 | 0.090 |
Why?
|
| Young Adult | 4 | 2023 | 4268 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 935 | 0.080 |
Why?
|
| Aged | 5 | 2023 | 6741 | 0.070 |
Why?
|
| Adolescent | 3 | 2023 | 5363 | 0.070 |
Why?
|
| Risk Factors | 4 | 2016 | 3562 | 0.060 |
Why?
|
| Social Justice | 1 | 2005 | 55 | 0.060 |
Why?
|
| Motor Activity | 1 | 2006 | 418 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2019 | 1378 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2019 | 1492 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2023 | 138 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 276 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2022 | 146 | 0.050 |
Why?
|
| Weight Loss | 1 | 2021 | 131 | 0.050 |
Why?
|
| Psychometrics | 1 | 2022 | 318 | 0.040 |
Why?
|
| Prevalence | 1 | 2023 | 1455 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 923 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 494 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2020 | 179 | 0.040 |
Why?
|
| Multigene Family | 1 | 2017 | 106 | 0.040 |
Why?
|
| Social Support | 1 | 2020 | 394 | 0.040 |
Why?
|
| Preventive Medicine | 1 | 2017 | 16 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 45 | 0.040 |
Why?
|
| Comorbidity | 1 | 2019 | 623 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2016 | 14 | 0.040 |
Why?
|
| Platelet Count | 1 | 2016 | 13 | 0.040 |
Why?
|
| Adipokines | 1 | 2016 | 24 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 36 | 0.030 |
Why?
|
| Mississippi | 1 | 2016 | 122 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 93 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 114 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 195 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 142 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 123 | 0.030 |
Why?
|
| Lipids | 1 | 2016 | 235 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 195 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 674 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 139 | 0.030 |
Why?
|
| Risk | 1 | 2014 | 267 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 362 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 293 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 885 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 465 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2016 | 322 | 0.030 |
Why?
|
| Women's Health | 1 | 2014 | 145 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 628 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1130 | 0.030 |
Why?
|
| Aging | 1 | 2016 | 664 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1067 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 854 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 485 | 0.020 |
Why?
|
| Health Care Reform | 1 | 2005 | 32 | 0.020 |
Why?
|
| Diastole | 1 | 2005 | 42 | 0.020 |
Why?
|
| Policy Making | 1 | 2005 | 31 | 0.020 |
Why?
|
| Systole | 1 | 2005 | 61 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2005 | 104 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 583 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 922 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2005 | 646 | 0.010 |
Why?
|
| Public Health | 1 | 2005 | 372 | 0.010 |
Why?
|